Cargando…
Immunotherapy for combined pulmonary fibrosis and emphysema with advanced lung cancer: two case reports and a concise review
BACKGROUND: It is unclear whether immunotherapy for combined pulmonary fibrosis and emphysema (CPFE) with advanced lung cancer (CPFE-LC) is safe. CASE DESCRIPTION: We reported on two cases of primary CPFE-LC, where the initial focus was on the lung cancer and not on the CPFE. The two patients underw...
Autores principales: | Tan, Xianglan, Tang, Xi, Jiang, Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9745352/ https://www.ncbi.nlm.nih.gov/pubmed/36523303 http://dx.doi.org/10.21037/tcr-22-1526 |
Ejemplares similares
-
Mortality in combined pulmonary fibrosis and emphysema patients is determined by the sum of pulmonary fibrosis and emphysema
por: Zhao, An, et al.
Publicado: (2021) -
Adenosine and hyaluronan promote lung fibrosis and pulmonary hypertension in combined pulmonary fibrosis and emphysema
por: Collum, Scott D., et al.
Publicado: (2019) -
The Syndrome of Combined Pulmonary Fibrosis and Emphysema
por: Zendah, Ines, et al.
Publicado: (2011) -
Combined pulmonary fibrosis and emphysema with lung cancer: Triple calamity
por: Ayub, Irfan Ismail, et al.
Publicado: (2019) -
Prognosis of combined pulmonary fibrosis and emphysema: comparison
with idiopathic pulmonary fibrosis alone
por: Jiang, Chun-guo, et al.
Publicado: (2019)